VS
Compare First Trust NYSE Arca Biotechnology ETF (FBT) vs BMO Equal Weight US Health Care Index ETF (ZHU) to find the best fit for your portfolio. FBT and ZHU provide the same top sector exposures: Healthcare. When evaluating costs, FBT features a management fee (MER) of 0.15%, compared to 0.35% for ZHU. Performance-wise, FBT has returned 33.76% year-to-date with +$4 M in net flows, whereas ZHU is at 16.96% with +$0 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
FBT
ZHU
| AuM | $7.64 M | $11.41 M |
| Management Fees | 0.15% | 0.35% |
| Exp. ratio | 0.71% | 0.40% |
| Tracking Difference | - | 2.33% |
Historical performance and flows
As of September 23, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | FBT | +1.92% | +15.81% | +33.76% | +52.73% | +93.79% |
ZHU | +0.23% | +13.50% | +16.96% | +26.72% | +34.58% | |
| Flows | FBT | +$0 M | +$2 M | +$4 M | +$4 M | +$4 M |
ZHU | +$0 M | +$0 M | +$0 M | +$0 M | -$6 M |
FBT vs ZHU exposure
Countries
FBT
USA
82.19%
Other
17.81%
ZHU
USA
95.10%
Sectors
FBT
Healthcare
99.86%
ZHU
Healthcare
100.00%
As of September 23, 2026
Top 10 Holdings
FBT
Halozyme Therapeutics, Inc.
4.31%
Corcept Therapeutics, Inc.
4.08%
Repligen Corp.
3.87%
Regeneron Pharmaceuticals, Inc.
3.85%
BeOne Medicines Ltd.
3.83%
BioNTech SE
3.75%
Natera, Inc.
3.73%
Amgen, Inc.
3.70%
argenx SE
3.66%
NeoGenomics, Inc.
3.63%
ZHU
Humana, Inc.
2.33%
Revolution Medicines, Inc.
2.23%
Guardant Health, Inc.
1.91%
Illumina, Inc.
1.88%
DaVita, Inc.
1.80%
Baxter International, Inc.
1.73%
UnitedHealth Group, Inc.
1.69%
Neurocrine Biosciences, Inc.
1.65%
Jazz Pharmaceuticals Plc
1.62%
Centene Corp.
1.59%
Diversification
FBT
Total weight of top 10 holdings out of 30 total
38.41%
ZHU
Total weight of top 10 holdings out of 79 total
18.42%
Characteristics
Compare
FBT
ZHU
| Provider | First Trust | BMO |
| Management | Passively managed | Passively managed |
| Benchmark | NYSE Arca Biotechnology Total Return Index - USD | Solactive Equal Weight US Health Care Canadian Dollar Hedged Total Return Index - CAD |
| Replication Method | Direct (Physical) | |
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 0.00% | 0.46% |
| Meets ESG criteria | No | No |
| Inception Date | October 30, 2014 | February 15, 2019 |
Frequently asked questions about FBT and ZHU
Which ETF has performed better year to date: FBT or ZHU?
As of September 23, 2026, FBT has returned 33.76% year to date, while ZHU has returned 16.96%. FBT is ahead on YTD performance.
Which ETF is larger by assets under management: FBT or ZHU?
As of September 23, 2026, FBT manages $7.64 M in assets, while ZHU manages $11.41 M. ZHU is the larger fund by AUM.
How are FBT and ZHU managed?
FBT is passively managed by First Trust. It tracks the NYSE Arca Biotechnology Total Return Index - USD benchmark. ZHU is passively managed by BMO. It tracks the Solactive Equal Weight US Health Care Canadian Dollar Hedged Total Return Index - CAD benchmark.
What sectors do FBT and ZHU emphasize?
FBT is most exposed to Healthcare. ZHU is most exposed to Healthcare.
Which ETF is attracting more investor flows: FBT or ZHU?
Year to date, FBT has seen +$4.36 M in net flows, compared with +$0.00 M for ZHU. FBT has attracted more net investor money so far.
How do the fees of FBT and ZHU compare?
FBT has an expense ratio of 0.71%, while ZHU has an expense ratio of 0.40%.
What are the top holdings of FBT and ZHU?
FBT's largest holdings include Halozyme Therapeutics, Inc., Corcept Therapeutics, Inc., and Repligen Corp.. ZHU's top holdings include Humana, Inc., Revolution Medicines, Inc., and Guardant Health, Inc..
Which ETF is more diversified: FBT or ZHU?
FBT holds 30 securities, while ZHU holds 79. On holdings count, ZHU is the more diversified portfolio.
Recent articles about FBT and ZHU
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.